Publication | Closed Access

Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment

Autoimmune DiseaseGenetic DisorderImmunodeficienciesInherited Metabolic DiseaseImmunologyGenetic EpidemiologyPathologyHematologyExtended HaplotypeProtease Inhibitor TherapyIndinavir TreatmentMedicineGenetic MedicineInborn Error Of ImmunityVariant InterpretationClinical Genetics